company background image
A032620 logo

UBcare KOSDAQ:A032620 Stock Report

Last Price

₩3.53k

Market Cap

₩178.9b

7D

-2.9%

1Y

-25.3%

Updated

21 Dec, 2024

Data

Company Financials

UBcare. Co., Ltd.

KOSDAQ:A032620 Stock Report

Market Cap: ₩178.9b

A032620 Stock Overview

Provides health care solutions in South Korea and internationally. More details

A032620 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends1/6

My Notes

Capture your thoughts, links and company narrative

UBcare. Co., Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for UBcare
Historical stock prices
Current Share Price₩3,525.00
52 Week High₩7,910.00
52 Week Low₩3,140.00
Beta1.07
1 Month Change0.14%
3 Month Change-11.43%
1 Year Change-25.32%
3 Year Change-53.74%
5 Year Change-39.22%
Change since IPO-45.77%

Recent News & Updates

Is UBcare (KOSDAQ:032620) A Risky Investment?

Nov 01
Is UBcare (KOSDAQ:032620) A Risky Investment?

UBcare (KOSDAQ:032620) Might Be Having Difficulty Using Its Capital Effectively

Aug 07
UBcare (KOSDAQ:032620) Might Be Having Difficulty Using Its Capital Effectively

These 4 Measures Indicate That UBcare (KOSDAQ:032620) Is Using Debt Reasonably Well

Jun 12
These 4 Measures Indicate That UBcare (KOSDAQ:032620) Is Using Debt Reasonably Well

Recent updates

Is UBcare (KOSDAQ:032620) A Risky Investment?

Nov 01
Is UBcare (KOSDAQ:032620) A Risky Investment?

UBcare (KOSDAQ:032620) Might Be Having Difficulty Using Its Capital Effectively

Aug 07
UBcare (KOSDAQ:032620) Might Be Having Difficulty Using Its Capital Effectively

These 4 Measures Indicate That UBcare (KOSDAQ:032620) Is Using Debt Reasonably Well

Jun 12
These 4 Measures Indicate That UBcare (KOSDAQ:032620) Is Using Debt Reasonably Well

UBcare. Co., Ltd. (KOSDAQ:032620) Held Back By Insufficient Growth Even After Shares Climb 34%

Feb 27
UBcare. Co., Ltd. (KOSDAQ:032620) Held Back By Insufficient Growth Even After Shares Climb 34%

Shareholder Returns

A032620KR Healthcare ServicesKR Market
7D-2.9%-13.5%-3.7%
1Y-25.3%-33.5%-10.4%

Return vs Industry: A032620 exceeded the KR Healthcare Services industry which returned -33.5% over the past year.

Return vs Market: A032620 underperformed the KR Market which returned -10.4% over the past year.

Price Volatility

Is A032620's price volatile compared to industry and market?
A032620 volatility
A032620 Average Weekly Movement8.1%
Healthcare Services Industry Average Movement11.1%
Market Average Movement6.6%
10% most volatile stocks in KR Market12.7%
10% least volatile stocks in KR Market3.3%

Stable Share Price: A032620 has not had significant price volatility in the past 3 months compared to the KR market.

Volatility Over Time: A032620's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1992324Sang-Kyoung Leewww.ubcare.net

UBcare. Co., Ltd. provides health care solutions in South Korea and internationally. The company offers medical IT services, such as Ysarang, an EMR system for hospital/clinic use; and U Pharm, an integrated management control system for pharmacies, hospitals, clinics, and pharmacy environments; and Big Ysarang, an EMR system for small and medium-sized hospitals, as well as customer management and media services. It is also involved in the medical distribution business that suggests products and services, such as high-technology medical equipment/devices for hospitals, clinics, pharmacies, medical e-commerce businesses, and shop-in-shop for health functional food; and provision of customized services.

UBcare. Co., Ltd. Fundamentals Summary

How do UBcare's earnings and revenue compare to its market cap?
A032620 fundamental statistics
Market cap₩178.87b
Earnings (TTM)-₩790.97m
Revenue (TTM)₩179.62b

1.0x

P/S Ratio

-226.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A032620 income statement (TTM)
Revenue₩179.62b
Cost of Revenue₩90.97b
Gross Profit₩88.65b
Other Expenses₩89.44b
Earnings-₩790.97m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-15.59
Gross Margin49.36%
Net Profit Margin-0.44%
Debt/Equity Ratio12.0%

How did A032620 perform over the long term?

See historical performance and comparison

Dividends

1.7%

Current Dividend Yield

-385%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 04:04
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

UBcare. Co., Ltd. is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Song-hyup HanDaishin Securities Co. Ltd.
Sang-Hun LeeiM Securities
Ju-Hong ChoeLS Securities Co., Ltd.